FDA Clearance Tracker · P030017-S270
PRECISION SPINAL CORD STIMULATION(SCS) SYSTEM
Last checked: Nov 20, 2026Latest source record: Aug 30, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Aug 30, 2017
Approved
Time to decision
259 days
Received Dec 14, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P030017-S270
- Device name
- PRECISION SPINAL CORD STIMULATION(SCS) SYSTEM
- Applicant
- Boston Scientific Corp
- Applicant location
- Valencia, CA
- Received
- Dec 14, 2016
- Decided
- Aug 30, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P030017
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a labeling change to designate Nevro Senza SCS System percutaneous leads and extensions as compatible to Boston Scientific Precision SCS devices (Implantable Pulse Generator, OR cable and extension/external trial stimulator (ETS), lead extensions, and tunneling tool) in the Directions for Use.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.